NUVL
Nuvalent, Inc. · Healthcare
Insiders sold $21.6M net in the last 90 days ·5 sellers, 0 buyers· 14 of 14 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 10, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$97.7M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Jul 15, 2026
Pelish Henry E.
Nuvalent, Inc. (NUVL) has 70 SEC Form 4 filings (259 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jul 15, 2026.
Inside the rolling window, 8 insiders at Nuvalent, Inc. reported no open-market purchases and 54 open-market sales totaling $97.7M. The most active filer is Chief Development Officer Noci Darlene with 13 filings. Insiders have net sold $39.6M over the trailing 6 months. The most recent open-market filing is a sale of 2,111 shares by Chief Scientific Officer Pelish Henry E., dated Jul 9, 2026, worth $261K.
- Industry:Biotechnology
- CEO:James R. Porter
- Employees:234
- HQ:Cambridge, MA, US
- IPO:2021-07-29
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 2,111 | $261K | Jul 10 | +0.0% | SEC ↗ | |
| President and CEO | Sale | 30,000 | $3.7M | Jul 8 | +0.1% | SEC ↗ | |
| Chief Financial Officer | Sale | 11,430 | $1.4M | Jul 6 | +0.2% | SEC ↗ | |
| Chief Development Officer | Sale | 23,000 | $2.8M | Jul 6 | +0.2% | SEC ↗ | |
| Chief Development Officer | Sale | 5,500 | $679K | Jul 1 | +0.3% | SEC ↗ | |
| Chief Development Officer | Sale | 20,000 | $2.5M | Jun 11 | +0.4% | SEC ↗ | |
| President and CEO | Sale | 30,000 | $2.7M | Jun 10 | +0.5% | SEC ↗ | |
| Chief Financial Officer | Sale | 11,430 | $1.1M | Jun 3 | +37.5% | SEC ↗ | |
| Chief Development Officer | Sale | 5,500 | $593K | Jun 1 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 5,500 | $593K | Jun 1 | — | SEC ↗ | |
| President and CEO | Sale | 30,000 | $3.1M | May 6 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 11,430 | $1.1M | May 5 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 5,500 | $546K | May 1 | — | SEC ↗ | |
| Chief Development Officer | Sale | 5,500 | $548K | May 1 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,093 | $323K | Apr 13 | — | SEC ↗ | |
| President and CEO | Sale | 30,000 | $3.1M | Apr 8 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 11,430 | $1.2M | Apr 3 | — | SEC ↗ | |
| Chief Development Officer | Sale | 5,500 | $538K | Apr 1 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 5,500 | $543K | Mar 30 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 11,430 | $1.1M | Mar 26 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 13,700 | $1.4M | Mar 26 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 30,000 | $2.9M | Mar 16 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 5,104 | $505K | Mar 16 | — | SEC ↗ | |
| President and CEO | Sale | 30,000 | $3.0M | Mar 10 | — | SEC ↗ | |
| Chief Development Officer | Sale | 5,500 | $567K | Mar 2 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does NUVL have?
Nuvalent, Inc. (NUVL) has 70 SEC Form 4 filings (259 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Jul 15, 2026.
When was the most recent SEC Form 4 filing for NUVL?
The most recent Form 4 filing for NUVL on Tracefour is dated Jul 15, 2026.
Who is the most active insider at NUVL?
The most active SEC Form 4 filer at NUVL in the rolling window is Chief Development Officer Noci Darlene, with 13 filings.
What is the net insider flow at NUVL over the last 6 months?
Over the trailing 180 days, insiders at NUVL have net sold $39.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NUVL in the current window?
Inside the rolling window, insiders at NUVL bought $0 and sold $97.7M based on SEC Form 4 filings.
Can I get alerts for NUVL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Nuvalent, Inc. (NUVL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Nuvalent, Inc. is in the Healthcare sector.